Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about ZafgenInc-2018-03-16
$69.0 Million
Image
Zafgen, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about SyrosPharmaceuticalsInc-2018-01-31
$46.0 Million
Image
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about SynlogicInc-2018-01-24
$57.5 Million
Image
Synlogic, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about AdverumBiotechnologiesInc-2018-02-08
$69.0 Million
Image
Adverum Biotechnologies, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about FateTherapeuticsInc-2017-12-13
$46.0 Million
Image
Fate Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about ImmunoVaccineIMVInc-2020-10-16
$50.0 Million
Image
ImmunoVaccine (IMV, Inc.)
At the Market Offering
Active Bookrunner
Read more
about ImmunoVaccineIMVInc-2020-07-20
$30.0 Million
Image
ImmunoVaccine (IMV, Inc.)
At the Market Offering
Active Bookrunner
Read more
about Paragon28Inc-2021-10-25
$143.8 Million
Image
Paragon 28, Inc.
Initial Public Offering
Active Bookrunner
Read more
about AvantorInc-2019-05-16
$3.3 Billion
Image
Avantor, Inc.
Initial Public Offering
Active Bookrunner
Read more
about SilverSpikeInvestmentCorp-2022-02-03
$85.0 Million
Image
Silver Spike Investment Corp
Initial Public Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 28
Next page
››
Subscribe to Active Bookrunner